Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.

Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, Thamarangsi T, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. 2013;381(9867):670-9.

Boutayeb A, Boutayeb SJIjfeih. The burden of non communicable diseases in developing countries. 2005;4(1):1-8.

Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. The Lancet. 2018;391(10134):2029-35.

Schmidt H, Barnhill A. Equity and noncommunicable disease reduction under the sustainable development goals. PLoS medicine. 2015;12(9):e1001872.

Azadnajafabad S, Mohammadi E, Aminorroay a A, Fattahi N, Rezaei S, Haghshenas R, Rezaei N, Naderimagham S, Larijani B, Farzadfar F. Noncommunicable diseases' risk factors in Iran; a review of the present status and action plans. J Diabetes Metab Disord. 2021 Jan 22;23(2):1-9. doi: 10.1007/s40200-020-00709-8. Epub ahead of print. PMID: 33500879; PMCID: PMC7821170.

Peykari N, Hashemi H, Asghari G, Ayazi M, Janbabaei G, Malekzadeh R, et al. Scientometric study on non-communicable diseases in Iran: a review article. Iranian Journal of Public Health. 2018;47(7):936.

Kass NE. An Ethics Framework for Public Health. American Journal of Public Health. 2001;91(11):1776.

Schmidt H. Chronic Disease Prevention and Health Promotion. In: H. Barrett D, W. Ortmann L, Dawson A, Saenz C, Reis A, Bolan G, eds. Public Health Ethics: Cases Spanning the Globe. Cham (CH): Springer; April 13, 2016.137-176.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews. 2021;10(1):89-.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557-60.

Bausch FJ, Beran D, Hering H, Boulle P, Chappuis F, Dromer C, et al. Operational considerations for the management of non-communicable diseases in humanitarian emergencies. Conflict and health. 2021;15(1):9.

Zahedi F, Razavi S, Larijani B. A two-decade review of medical ethics in Iran. Iranian Journal of Public Health. 2009;38(Suppl. 1):40-6.

Venkatapuram S, McKee M, Stuckler D. Ethical tensions in dealing with noncommunicable diseases globally. Bulletin of the World Health Organization. 2012;90(3):241.

Organization WH. Commission on social determinants of health-CSDH. 2008.

Organization WJWH. Noncommunicable diseases progress monitor 2017. 2017.

Kickbusch I, Allen L, Franz C. The commercial determinants of health. The Lancet Global Health. 2016;4(12):e895-e6.

Organisation WH. WHO Director-General addresses health promotion conference. The 8th Global Conference on Health Promotion in Helsinki 2013 [Available from: https://www.who.int/director-general/speeches/detail/who-director-general-addresses-health-promotion-conference.]

Latapí Agudelo, M.A., Jóhannsdóttir, L. & Davídsdóttir, B. A literature review of the history and evolution of corporate social responsibility. Int J Corporate Soc Responsibility 4, 1 (2019). https://doi.org/10.1186/s40991-018-0039-y.

Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study. PloS one. 2019;14(2):e0211622.

Khajavi A, Pishgar F, Dehghani M, Naderimagham S. Socioeconomic inequalities in neonatal and postneonatal mortality: evidence from rural Iran, 1998–2013. International Journal for Equity in Health. 2017;16(1):1-11.

Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. The Lancet. 2013;381(9866):585-97.

AbdulRaheem Y. Unveiling the Significance and Challenges of Integrating Prevention Levels in Healthcare Practice. J Prim Care Community Health. 2023;14:21501319231186500.

Fowler T, Garr D, Mager NDP, Stanley J. Enhancing primary care and preventive services through Interprofessional practice and education. Isr J Health Policy Res. 2020;9(1):12.

Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381(9866):585-97.

Beran D, Pedersen HB, Robertson J. Noncommunicable diseases, access to essential medicines and universal health coverage. Glob Health Action. 2019;12(1):1670014.

Fisher M, Freeman T, Mackean T, Friel S, Baum F. Universal Health Coverage for Non-communicable Diseases and Health Equity: Lessons From Australian Primary Healthcare. Int J Health Policy Manag. 2022;11(5):690-700.

Biswas T, Islam MS, Linton N, Rawal LB. Socio-Economic Inequality of Chronic Non-Communicable Diseases in Bangladesh. PLOS ONE. 2016;11(11):e0167140.

Venkatapuram S, McKee M, Stuckler DJBotWHO. Ethical tensions in dealing with noncommunicable diseases globally. 2012;90(3):241-2.

CAPP S, SAVAGE S, CLARKE V. Exploring distributive justice in health care %J Australian Health Review. 2001;24(2):40-4.

Nugent R. A Chronology of Global Assistance Funding for NCD. Global heart. 2016;11(4):371-4.

Jailobaeva K, Falconer J, Loffreda G, Arakelyan S, Witter S, Ager A. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries. Globalization and health. 2021;17(1):68.

Luna F, Luyckx VA. Why have Non-communicable Diseases been Left Behind? Asian bioethics review. 2020;12(1):5-25.

Warren Andersen S, Zheng W, Sonderman J, Shu XO, Matthews CE, Yu D, et al. Combined Impact of Health Behaviors on Mortality in Low-Income Americans. American journal of preventive medicine. 2016;51(3):344-55.

Nguyen TP, Rokhman MR, Stiensma I, Hanifa RS, Ong TD, Postma MJ, van der Schans J. Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review. Front Public Health. 2023;11:1206213.

Lee LM. Public health ethics theory: review and path to convergence. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2012;40(1):85-98.

Finkelstein EA, Bilger M, Baid D. Effectiveness and cost-effectiveness of incentives as a tool for prevention of non-communicable diseases: A systematic review. Social Science & Medicine. 2019;232:340-50.

Ndubuisi NE. Noncommunicable Diseases Prevention In Low- and Middle-Income Countries: An Overview of Health in All Policies (HiAP). Inquiry. 2021;58:46958020927885.

Bertram MY, Chisholm D, Watts R, Waqanivalu T, Prasad V, Varghese C. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis. Int J Health Policy Manag. 2021;10(11):724-33.

Organization WH. Noncommunicable diseases progress monitor 2022. 2022.

Jackson-Morris AM, Mutungi G, Maree E, Waqanivalu T, Marten R, Nugent R. ‘Implementability’ matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries. BMJ Global Health. 2022;7(4):e008275.

Peters DH, Adam T, Alonge O, Agyepong IA, Tran NJB. Implementation research: what it is and how to do it. 2013;347.

Abbasloo F, Ebrahimi P, Ghadimi D, et al. The evaluation of depression prevalence and its association with obesity phenotypes in a community-dwelling aged population. Aging Clin Exp Res. 2024;37(1):2. Published 2024 Dec 21.

Peters D, Tran N, Adam TJWHO. Alliance for Health Policy and Systems Research, WHO. Implementation Research in Health: A Practical Guide [Internet]. 2021.

Carlson V, Chilton MJ, Corso LC, Beitsch LM. Defining the functions of public health governance. American journal of public health. 2015;105(S2):S159-S66.

Ortmann LW. Defining Public Health Ethics for Practitioners. Narrative Ethics in Public Health: The Value of Stories: Springer International Publishing Cham; 2022. p. 3-22.

Ebrahimi P, Payab M, Taheri M. et al. Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report. Int J Emerg Med 17, 195 (2024).

Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet. 2020;395(10238):1715-25.

Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review. Journal of internal medicine. 2021;289(4):450-62.

Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HH, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet Global Health. 2020;8(8):e1003-e17.

Kursite M, Stars I, Strēle I, Gobiņa I, Ķīvīte-Urtāne A, Behmane D, et al. A mixed-method study on the provision of remote consultations for non-communicable disease patients during the first wave of the COVID-19 pandemic in Latvia: lessons for the future. BMC Health Services Research. 2022;22(1):1-15.

Ehsanipur F, Ebrahimi P, Tahernia L, Vafaee-Shahi M. A fulminant presentation of post-COVID-19 necrotizing pneumonia and ischemic stroke in an 8-year-old girl: A case report and literature review. Clinical Case Reports. 2024;12(8):e9222.

Varnaseri M, Amini F, Jamshididan R, Dargahi M, Gheibi N, Abolghasemi S, et al. Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial. Jundishapur J Health Sci. 2024;16(2):e146703.

Edwards HB, Marques E, Hollingworth W, Horwood J, Farr M, Bernard E, et al. Use of a primary care online consultation system, by whom, when and why: evaluation of a pilot observational study in 36 general practices in South West England. BMJ Open. 2017;7(11):e016901.

Bagot KL, Cadilhac DA, Bladin CF, Watkins CL, Vu M, Donnan GA, et al. Integrating acute stroke telemedicine consultations into specialists’ usual practice: a qualitative analysis comparing the experience of Australia and the United Kingdom. BMC Health Services Research. 2017;17(1):751.

Stamenova V, Agarwal P, Kelley L, Fujioka J, Nguyen M, Phung M, et al. Uptake and patient and provider communication modality preferences of virtual visits in primary care: a retrospective cohort study in Canada. BMJ Open. 2020;10(7):e037064.

Greenhalgh T, Shaw S, Wherton J, Vijayaraghavan S, Morris J, Bhattacharya S, et al. Real-World Implementation of Video Outpatient Consultations at Macro, Meso, and Micro Levels: Mixed-Method Study. J Med Internet Res. 2018;20(4):e150.

Donaghy E, Atherton H, Hammersley V, McNeilly H, Bikker A, Robbins L, et al. Acceptability, benefits, and challenges of video consulting: a qualitative study in primary care. British Journal of General Practice. 2019;69(686):e586.

Wang H, Yuan X, Wang J, Sun C, Wang G. Telemedicine maybe an effective solution for management of chronic disease during the COVID-19 epidemic. Primary Health Care Research & Development. 2021;22:e48.